Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

720 ARTÍCULOS , VIENDO DEL 361 AL 375

Recent Advances in Therapeutics for the Treatment of Alzheimer's Disease

Thawabteh AM, Ghanem AW, AbuMadi S, Thaher D, Jaghama W, Karaman D, Karaman R.

Molecules. 2024 Oct 30;29(21):5131. doi: 10.3390/molecules29215131.

Dual inhibition of butyrylcholinesterase and p38α mitogen-activated protein kinase: A new approach for the treatment of Alzheimer's disease

Ferjančič Benetik S, Knez D, Obreza A, Košak U, Gobec S.

Pharmacol Ther. 2024 Dec;264:108748. doi: 10.1016/j.pharmthera.2024.108748. Epub 2024 Nov 7.

Insights on therapeutic approaches of natural anti-Alzheimer's agents in the management of Alzheimer's disease: A future perspective

Mahajan K, Sharma S, Gautam RK, Goyal R, Mishra DK, Singla RK.

J Alzheimers Dis. 2024 Dec;102(4):897-923. doi: 10.1177/13872877241296557. Epub 2024 Nov 10.

The phospho-tau cascade, basal forebrain neurodegeneration, and dementia in Alzheimer's disease: Anti-neurodegenerative benefits of acetylcholinesterase inhibitors

Moss DE, Perez RG.

J Alzheimers Dis. 2024 Dec;102(3):617-626. doi: 10.1177/13872877241289602. Epub 2024 Nov 12.

Dietary interventions in mitigating the impact of environmental pollutants on Alzheimer's disease - A review

Khandayataray P, Murthy MK.

Neuroscience. 2024 Dec 17;563:148-166. doi: 10.1016/j.neuroscience.2024.11.020. Epub 2024 Nov 13.

Endothelial Dysfunctions in Blood-Brain Barrier Breakdown in Alzheimer's Disease: From Mechanisms to Potential Therapies

Yue Q, Leng X, Xie N, Zhang Z, Yang D, Hoi MPM.

CNS Neurosci Ther. 2024 Nov;30(11):e70079. doi: 10.1111/cns.70079.

Passive anti-amyloid β immunotherapy in Alzheimer's disease-opportunities and challenges

Heneka MT, Morgan D, Jessen F.

Lancet. 2024 Nov 30;404(10468):2198-2208. doi: 10.1016/S0140-6736(24)01883-X. Epub 2024 Nov 14.

Phase 1 Studies of the Anti-Tau Monoclonal Antibody JNJ-63733657 in Healthy Participants and Participants with Alzheimer's Disease

Galpern WR, Triana-Baltzer G, Li L, Van Kolen K, Timmers M, Haeverans K, Janssens L, Kolb H, Nandy P, Aida K, Shimizu H, Mercken M, Sun H.

J Prev Alzheimers Dis. 2024;11(6):1592-1603. doi: 10.14283/jpad.2024.163.

Roles of TREM2 in the Pathological Mechanism and the Therapeutic Strategies of Alzheimer's Disease

Lin M, Yu JX, Zhang WX, Lao FX, Huang HC.

J Prev Alzheimers Dis. 2024;11(6):1682-1695. doi: 10.14283/jpad.2024.164.

A Pilot Electroencephalography Study of the Effect of CT1812 Treatment on Synaptic Activity in Patients with Mild to Moderate Alzheimer's Disease

Vijverberg E, de Haan W, Scheijbeler E, Hamby ME, Catalano S, Scheltens P, Grundman M, Caggiano AO.

J Prev Alzheimers Dis. 2024;11(6):1809-1817. doi: 10.14283/jpad.2024.154.

The emerging field of non-invasive brain stimulation in Alzheimer's disease

Koch G, Altomare D, Benussi A, Bréchet L, Casula EP, Dodich A, Pievani M, Santarnecchi E, Frisoni GB.

Brain. 2024 Dec 3;147(12):4003-4016. doi: 10.1093/brain/awae292.

The new perspective of Alzheimer's Disease Research: Mechanism and therapeutic strategy of neuronal senescence

Niu Q, Li D, Zhang J, Piao Z, Xu B, Xi Y, Mohamed Kamal NNSN, Lim V, Li P, Yin Y.

Ageing Res Rev. 2024 Dec;102:102593. doi: 10.1016/j.arr.2024.102593. Epub 2024 Nov 19.

Research progress on the association of insulin resistance with type 2 diabetes mellitus and Alzheimer's disease

Zheng M, Wang C, Hu M, Li Q, Li J, Quan S, Zhang X, Gu L.

Metab Brain Dis. 2024 Nov 21;40(1):35. doi: 10.1007/s11011-024-01472-y.

Animal models of Alzheimer's disease: Current strategies and new directions

Wang Q, Zhu BT, Lei P.

Zool Res. 2024 Nov 18;45(6):1385-1407. doi: 10.24272/j.issn.2095-8137.2024.274.

A randomized clinical trial evaluating Hydralazine's efficacy in early-stage Alzheimer's disease: The EHSAN Study

Mirzaei M, Ahmadi N, Bagheri Fahraji B, Ardekani AM, Rahimdel A, Soltani MH, Ardekani SMY, Bidaki R, Kasnavie FH, Dastjerdi G, Aboutorabi M, Mirzaei H.

Sci Rep. 2024 Nov 21;14(1):28837. doi: 10.1038/s41598-024-79616-4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias